This study established a risk model comprising OSMR, G0S2, IGFBP6, IGHG2, and FMOD based on ferroptosis classification and verified the value of this model in predicting the survival prognosis of GBM patients. This evidence concerns the gene IGFBP6 and glioblastoma.